Epithelial Ovarian Cancer Pathology and Inflammation Associated Molecular Targets
Is There a Role for Non-steroidal Anti-inflammatory Drugs (NSAIDS) in EOC Prevention?
Anti-inflammatory Phytochemicals
In conclusion, results from many published studies described above indicate a definitive involvement of inflammation pathway in the progression and treatment of ovarian cancer. Some anti-inflammatory phytochemicals exhibit the activities to intervene the dysregulated inflammation pathway, and may play a beneficial role in the treatment of advanced EOC. However, there are many questions remain to be answered. Further research in this area is urgently needed.
http://ovariancancerandus.blogspot.com/feeds/posts/default
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.